Autologous Transplant versus Chimeric Antigen Receptor T-Cell Therapy for Relapsed DLBCL in Partial Remission

Researchers identified adult diffuse large B-cell lymphoma (DLBCL) patients who received either an auto-hematopoietic cell transplant or CAR-T treatment with axicabtagene ciloleucelwhile in a partial remission by CT or PET scan.